Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.39 | 4e-23 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.35 | 3e-21 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.36 | 3e-20 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.34 | 8e-20 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.33 | 5e-19 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-18 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.49 | 1e-18 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-17 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-17 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.34 | 8e-17 |